ENROFLOXACIN FLAVORED- enrofloxacin tablet, chewable United States - English - NLM (National Library of Medicine)

enrofloxacin flavored- enrofloxacin tablet, chewable

putney, inc. - enrofloxacin (unii: 3dx3xek1bn) (enrofloxacin - unii:3dx3xek1bn) - enrofloxacin 22.7 mg - enrofloxacin flavored tablets are indicated for the management of diseases associated with bacteria susceptible to enrofloxacin. enrofloxacin flavored tablets are indicated for use in dogs and cats. enrofloxacin is contraindicated in dogs and cats known to be hypersensitive to quinolones. dogs: based on the studies discussed under the section on animal safety summary, the use of enrofloxacin is contraindicated in small and medium breeds of dogs during the rapid growth phase (between 2 and 8 months of age). the safe use of enrofloxacin has not been established in large and giant breeds during the rapid growth phase. large breeds may be in this phase for up to one year of age and the giant breeds for up to 18 months. in clinical field trials utilizing a daily oral dose of 5.0 mg/kg, there were no reports of lameness or joint problems in any breed. however, controlled studies with histological examination of the articular cartilage have not been conducted in the large or giant breeds.

Baytril Flavour 150 mg tabl. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

baytril flavour 150 mg tabl.

bayer animal health gmbh - enrofloxacin 150 mg - tablet - 150 mg - enrofloxacin 150 mg - enrofloxacin - dog

Enrotron Flavour 150 mg tabl. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

enrotron flavour 150 mg tabl.

animedica gmbh - enrofloxacin 150 mg - tablet - 150 mg - enrofloxacin 150 mg - enrofloxacin - dog

Enrox Flavour 150 mg tabl. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

enrox flavour 150 mg tabl.

krka d.d. novo mesto d.d. - enrofloxacin 150 mg - tablet - 150 mg - enrofloxacin 150 mg - enrofloxacin - dog

Enroxal Flavour 150 mg tabl. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

enroxal flavour 150 mg tabl.

krka d.d. novo mesto d.d. - enrofloxacin 150 mg - tablet - 150 mg - enrofloxacin 150 mg - enrofloxacin - dog

Floxabactin 150 mg tabl. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

floxabactin 150 mg tabl.

le vet pharma b.v. - enrofloxacin 150 mg - tablet - 150 mg - enrofloxacin 150 mg - enrofloxacin - dog

Xeden 150 mg tabl. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

xeden 150 mg tabl.

ceva santé animale sa-nv - enrofloxacin 150 mg - tablet - 150 mg - enrofloxacin 150 mg - enrofloxacin - dog

Enrox Flavour 150 mg Tablets for dogs Ireland - English - HPRA (Health Products Regulatory Authority)

enrox flavour 150 mg tablets for dogs

krka, d.d., novo mesto - enrofloxacin - tablet - 150 mg/tablet - enrofloxacin - dogs - antibacterial

ENROFLOXACIN FLAVORED- enrofloxacin tablet United States - English - NLM (National Library of Medicine)

enrofloxacin flavored- enrofloxacin tablet

felix pharmaceuticals private limited - enrofloxacin (unii: 3dx3xek1bn) (enrofloxacin - unii:3dx3xek1bn) - enrofloxacin flavored tablets are indicated for the management of diseases associated with bacteria susceptible to enrofloxacin. enrofloxacin flavored tablets are indicated for use in dogs and cats. enrofloxacin is contraindicated in dogs and cats known to be hypersensitive to quinolones. dogs: based on the studies discussed under the section on animal safety summary, the use of enrofloxacin is contraindicated in small and medium breeds of dogs during the rapid growth phase (between 2 and 8 months of age). the safe use of enrofloxacin has not been established in large and giant breeds during the rapid growth phase. large breeds may be in this phase for up to one year of age and the giant breeds for up to 18 months. in clinical field trials utilizing a daily oral dose of 5.0 mg/kg, there were no reports of lameness or joint problems in any breed. however, controlled studies with histological examination of the articular cartilage have not been conducted in the large or giant breeds.

ENROFLOXACIN FLAVORED- enrofloxacin tablet United States - English - NLM (National Library of Medicine)

enrofloxacin flavored- enrofloxacin tablet

butler animal health supply, llc dba covetrus north america - enrofloxacin (unii: 3dx3xek1bn) (enrofloxacin - unii:3dx3xek1bn) - enrofloxacin flavored tablets are indicated for the management of diseases associated with bacteria susceptible to enrofloxacin. enrofloxacin flavored tablets are indicated for use in dogs and cats. enrofloxacin is contraindicated in dogs and cats known to be hypersensitive to quinolones. dogs: based on the studies discussed under the section on animal safety summary, the use of enrofloxacin is contraindicated in small and medium breeds of dogs during the rapid growth phase (between 2 and 8 months of age). the safe use of enrofloxacin has not been established in large and giant breeds during the rapid growth phase. large breeds may be in this phase for up to one year of age and the giant breeds for up to 18 months. in clinical field trials utilizing a daily oral dose of 5.0 mg/kg, there were no reports of lameness or joint problems in any breed. however, controlled studies with histological examination of the articular cartilage have not been conducted in the large or giant breeds.